Model building strategies for risk analysis of perioperative histamine-related cardiorespiratory disturbances

Inflamm Res. 1995 Apr:44 Suppl 1:S82-3. doi: 10.1007/BF01674407.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Cimetidine / therapeutic use
  • Dimethindene / therapeutic use
  • Histamine / physiology*
  • Histamine H1 Antagonists / therapeutic use
  • Histamine H2 Antagonists / therapeutic use
  • Humans
  • Intraoperative Complications*
  • Logistic Models*
  • Middle Aged
  • Prospective Studies
  • Respiratory Tract Diseases / etiology
  • Respiratory Tract Diseases / prevention & control*
  • Risk
  • Risk Factors

Substances

  • Histamine H1 Antagonists
  • Histamine H2 Antagonists
  • Dimethindene
  • Cimetidine
  • Histamine